Court sides with Amgen in Enbrel biosimilar patent case
The US District Court for the District of New Jersey ruled in Amgen’s favor on the validity of the two patents on Enbrel and the methods for making it.
Archives for August 13, 2019
Sanofi warns of delays to flu vaccine shipments
Sanofi warns that the World Health Organization’s delayed strain selection will push back the date on which it delivers vaccines for the 2019-2020 flu season.
Expanded approval of Dupixent scratches an unmet itch
The FDA approves targeted biologic, Dupixent, for the treatment of atopic dermatitis in patients 12 to 17 years old, the first treatment of its kind for adolescents.
Bayer acquires cell therapies developer BlueRock
Bayer to fully acquire BlueRock Therapeutics’ to build its cell therapy pipeline based on the latter’s induced pluripotent stem cell platform.